Corrigendum: Sesquiterpene lactones attenuate paclitaxel resistance via inhibiting MALAT1/STAT3/ FUT4 axis and P-Glycoprotein transporters in lung cancer cells.

[This corrects the article DOI: 10.3389/fphar.2022.795613.].

Real-time vehicle target detection in inclement weather conditions based on YOLOv4.

As a crucial component of the autonomous driving task, the vehicle target detection algorithm directly impacts driving safety, particularly in inclement weather situations, where the detection precision and speed are significantly decreased. This paper investigated the You Only Look Once (YOLO) algorithm and proposed an enhanced YOLOv4 for real-time target detection in inclement weather conditions. The algorithm uses the Anchor-free approach to tackle the problem of YOLO preset anchor frame and poor fit. It better adapts to the detected target size, making it suitable for multi-scale target identification. The improved FPN network transmits feature maps to unanchored frames to expand the model's sensory field and maximize the utilization of model feature data. Decoupled head detecting head to increase the precision of target category and location prediction. The experimental dataset BDD-IW was created by extracting specific labeled photos from the BDD100K dataset and fogging some of them to test the proposed method's practical implications in terms of detection precision and speed in Inclement weather conditions. The proposed method is compared to advanced target detection algorithms in this dataset. Experimental results indicated that the proposed method achieved a mean average precision of 60.3%, which is 5.8 percentage points higher than the original YOLOv4; the inference speed of the algorithm is enhanced by 4.5 fps compared to the original, reaching a real-time detection speed of 69.44 fps. The robustness test results indicated that the proposed model has considerably improved the capacity to recognize targets in inclement weather conditions and has achieved high precision in real-time detection.

Sesquiterpene Lactones Attenuate Paclitaxel Resistance Via Inhibiting MALAT1/STAT3/ FUT4 Axis and P-Glycoprotein Transporters in Lung Cancer Cells.

Paclitaxel resistance is a challenging factor in chemotherapy resulting in poor prognosis and cancer recurrence. Signal transducer and activator of transcription factor 3 (STAT3), a key transcription factor, performs a critical role in cancer development, cell survival and chemoresistance, while its inactivation overwhelms drug resistance in numerous cancer types including lung cancer. Additionally, the fucosyltransferase 4 (FUT4) is a crucial enzyme in post-translational modification of cell-surface proteins involved in various pathological conditions such as tumor multidrug resistance (MDR). The P-glycoprotein (P-GP) is the well-known ABC transporter member that imparts drug resistance in different cancer types, most notably paclitaxel resistance in lung cancer cells. LncRNA-MALAT1 exerts a functional role in the cancer development as well as the drug resistance and is linked with STAT3 activation and activity of FUT4. Moreover, STAT3-mediated induction of P-GP is well-documented. Natural compounds of Sesquiterpene Lactone (SL) family are well-known for their anticancer properties with particular emphasis over STAT3 inhibitory capabilities. In this study, we explored the positive correlation of MALAT1 with STAT3 and FUT4 activity in paclitaxel resistant A549 (A549/T) lung cancer cells. Additionally, we investigated the anticancer activity of two well-known members of SLs, alantolactone (ALT) and Brevilin A (Brv-A), in A549/T lung cancer cells. ALT and Brv-A induced apoptosis in A549/T cells. Furthermore, these two natural SLs suppressed MALAT1 expression, STAT3 activation, and FUT4 and P-GP expression which are the hallmarks for paclitaxel resistance in A549 lung cancer cells. The inhibition of MALAT1 enhanced the competence of these SLs members significantly, which accounted for the growth inhibition as well as anti-migratory and anti-invasive effects of ALT and Brv-A. These findings suggest SLs to be the promising agents for overcoming paclitaxel resistance in A549 lung cancer cells.

Outcome evaluation of neoadjuvant chemotherapy in patients with stage IB2 or IIA cervical cancer: a retrospective comparative study.

BACKGROUND: To study the benefits of neoadjuvant chemotherapy (NACT) in addition to surgical resection and postoperative chemoradiotherapy (CRT) in patients with stage IB2 or IIA cervical cancer. METHODS: We retrospectively analyzed 363 patients with stage IB2 or IIA cervical cancer that received the surgical resection and postoperative CRT with or without NACT at the Second Hospital of Jilin University between February 2014 and December 2016. We chose mortality as the primary outcome, and the clinical deterioration as secondary outcome. These outcomes were compared between two groups of patients with or without NACT by univariate or multivariate logistic regression analysis. RESULTS: Among the 363 identified patients, 114 patients were in the neoadjuvant group and 249 patients in the non-neoadjuvant group. The median follow-up period was 36.4 months, ranging from 28 to 55 months. There were statistically significant differences in the tumor differentiation, clinical stages, vascular tumor thrombus, and postoperative radiotherapy between these two group patients. After adjusting for these variables, patients in the neoadjuvant group had a statistically significantly lower survival rate than those in the non-neoadjuvant group within one year after the treatment, but this difference disappeared at the 3-year follow-up period. Also, more patients in the neoadjuvant group experienced clinical deterioration at the 3-year follow-up period. CONCLUSIONS: NACT did not show significant benefits in mortality and clinical deterioration in patients with stage IB2 or IIA cervical cancer.

Neoadjuvant chemotherapy does not improve the prognosis and lymph node metastasis rate of locally advanced cervical squamous cell carcinoma: A retrospective cohort study in China.

Locally advanced cervical carcinoma has a poor prognosis. Neoadjuvant chemotherapy (NACT) can reduce tumor size and improve tumor resection rate, but its use in large locally advanced cervical carcinoma is controversial. This study aimed to evaluate the treatment and prognosis of NACT in patients with cervical carcinoma stage IB2 or IIA2.This was a retrospective cohort study of patients who underwent type-C radical surgery and pelvic lymphadenectomy due to cervical carcinoma stage IB2/IIA2 between 2/2014 and 12/2016 at the Second Hospital of Jilin University. The patients were grouped according to whether they received NACT (paclitaxel and a platinum salt) or not. Overall survival (OS) and progression-free survival (PFS) were compared between the 2 groups.Of the 144 patients, 60 (41.7%) received NACT. A total of 119 patients underwent postoperative radiation therapy, of which 97 received radiation therapy alone and 22 received concurrent chemoradiotherapy. The adverse reactions in the NACT group were mainly hematologic toxic reactions, but were tolerated. No grade ≥III adverse reactions were observed. NACT did not significantly affect the PFS (P = .453) and OS (P = .933) between the 2 groups. No factor was found to be independently associated with OS or PFS (all P > .05).Compared with patients who underwent surgery with/without radiotherapy and/or chemotherapy, NACT using paclitaxel and a platinum salt does not improve the prognosis and lymph node metastasis rate of locally advanced cervical carcinoma in Chinese patients.

Prognostic value of lymphovascular space invasion in patients with early stage cervical cancer in Jilin, China: A retrospective study.

The metastasis of cervical carcinoma is associated with the lymphovascular spread. The primary objective of the present study was to determine the prognostic value of lymphovascular space invasion (LVSI) in patients with early-stage cervical cancer in Jilin, China.In this retrospective cohort study, patients with early-stage cervical cancer (stage IB-IIA) at the Second Hospital of Jilin University from February 2014 to December 2016 were included in the analysis. All included participants underwent radical hysterectomy with pelvic lymphadenectomy. LVSI was identified by hematoxylin and eosin (H&E) staining. The primary outcomes are overall survival (OS) and progression-free survival (PFS). Kaplan-Meier curves were used to calculate the patient's survival. Survival was compared using the log-rank test, while risk factors for the prognosis were assessed by Cox regression analysis.The incidence of LVSI was positively associated with the depth of stromal invasion (P = .009) and lymph node metastasis (LNM, P < .001). LVSI is an independent factor that affects OS (P = .009) and PFS (P = .006) in patients with early stage cervical cancer. LNM status is an independent factor that affects postoperative OS (P = .005).The incidence of lymphatic vessel infiltration is positively associated with the depth of stromal invasion and LNM. LVSI is an independent risk factor for the prognosis of early cervical cancer. The results suggest that further large-scale studies are needed to improve the treatment for patients with LVSI.

Application of a sensitive and accurate LC-MS/MS method for determination of dryocrassin ABBA in rat plasma for a bioavailability study.

A sensitive and accurate liquid chromatography-tandem mass spectrometry method was developed and validated for the determination of dryocrassin ABBA, a potential active component isolated from Dryopteris crassirhizoma, in rat plasma. Chromatographic separation was achieved on a Zorbax SB-C18 column (50 × 2.1 mm, 1.8 µm), with elution consisting of eluent (A) 10 mm ammonium acetate in methanol containing 0.1% formic acid and (B) 10 mm ammonium acetate in water containing 0.1% formic acid (A:B = 99:1, v/v) at a flow rate of 0.3 mL/min. Multiple reaction monitoring mode was used to monitor the precursor-product ion transitions of m/z 819.3 → 403.4 for dryocrassin ABBA and m/z 426.2 → 409.2 for internal standard. This assay exhibited a good linearity with a correlation coefficient >0.99 and showed no endogenous interference with the analyte and internal standard. The lower limit of quantification of dryocrassin ABBA was 4 ng/mL in 50 µL of rat plasma. The method was successfully applied in the pharmacokinetic study of dryocrassin ABBA in rats after intravenous (2.35 mg/kg) and oral (23.5 mg/kg) doses of dryocrassin ABBA. The oral bioavailability (F) of dryocrassin ABBA was estimated to be 50.1%. Our study is the first to clarify the pharmacokinetic behaviors of dryocrassin ABBA in animals.

Photodegradation of textile dye Rhodamine B over a novel biopolymer-metal complex wool-Pd/CdS photocatalysts under visible light irradiation.

A novel biopolymer-metal complex wool-Pd/CdS photocatalysts were prepared and exhibited high activity for photodegradation of Rh B under visible light irradiation. The wool-Pd could not only enhance the utilization rate of noble metal Pd but also significantly improve the activity of dye degradation. Wool-Pd was able to introduce Pd and PdS to effectively prohibit the recombination of photogenerated electrons and holes. The optimal weight percentage of wool-Pd in the photocatalyst was found to be 0.5wt%, which resulted in a good result of degradation of Rh B under visible light. It is obviously better in the catalyst efficiency than pure CdS. The photocatalysts were characterized by X-ray diffraction, diffuse reflectance UV-vis spectroscopy, energy-dispersive X-ray spectroscopy (EDX), X-ray photoelectron spectroscopic (XPS) studies, transmission electron microscopy (TEM). In a word, the prepared novel biopolymer-metal complex wool-Pd/CdS photocatalysts not only improve the degradation efficiency of Rh B, but also has a good advantage of recycling and cost-effective. It will have a good application prospect. In addition, the possible degradation pathway of Rh B was proposed in this paper.

[A research of stability method for non-dispersive infrared gas analysis based on multi-parameter model].

To non-dispersive infrared gas analysis, it was the most difficult challenge to maintain very low zero and temperature drift over long periods. Electronic and detector response drifts irremediably required some form of manual zeroing procedure. To solve zero and temperature drift, a multi-parameters model was developed, by which zero and temperature drifts were automatically corrected. These parameters include zero gas intensity, reference channels intensity, standard temperature, environment temperature, temperature drift coefficients etc. Trial results and in-situ applications showed that the monitoring precisions of the instrument were lesser than 5% F. S in different temperatures and for a long time. The average precision of monitoring carbon monoxide concentration increased respectively from 9.26 to 1.23%, and monitoring hydrocarbon concentration from 10.61% to 0.70% before and after compensated. The instrument required essentially no periodic calibration and have very low maintenance cost.